Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pathfinder Cell Therapy Inc (DE:LE1)
FRANKFURT:LE1
Pathfinder Cell Therapy (LE1) Stock Price & Analysis
0 Followers
LE1 Stock Chart & Stats
Day’s Range€0.04 - €0.04
52-Week Range― - ―
Previous Close€0.04
Volume0.00
Average Volume (3M)N/A
Market Cap
$604.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LE1 FAQ
What was Pathfinder Cell Therapy Inc’s price range in the past 12 months?
Currently, no data Available
What is Pathfinder Cell Therapy Inc’s market cap?
Currently, no data Available
When is Pathfinder Cell Therapy Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pathfinder Cell Therapy Inc’s earnings last quarter?
Currently, no data Available
Is Pathfinder Cell Therapy Inc overvalued?
According to Wall Street analysts Pathfinder Cell Therapy Inc’s price is currently Overvalued.
Does Pathfinder Cell Therapy Inc pay dividends?
Pathfinder Cell Therapy Inc does not currently pay dividends.
What is Pathfinder Cell Therapy Inc’s EPS estimate?
Pathfinder Cell Therapy Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pathfinder Cell Therapy Inc have?
Currently, no data Available
What happened to Pathfinder Cell Therapy Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pathfinder Cell Therapy Inc?
Currently, no hedge funds are holding shares in DE:LE1
---
Company Description
Pathfinder Cell Therapy Inc
Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded by Richard L. Franklin and Joerg Gruber on September 2, 2011 and is headquartered in Cambridge, MA.
---
Advaxis
―
Cidara Therapeutics
―
Pulmatrix
―
Agile Therapeutics
―
Pathfinder Cell Therapy
―
---